Is amiodarone safe in heart failure?

British Medical Journal

Volumn 332, Issue 7537, 2006, Pages 317-318

  Coceani, Michele ^a   Mariotti, Rita ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR; AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR; CALCIUM; CYCLOOXYGENASE 2 INHIBITOR; DIGOXIN; DIURETIC AGENT; DRONEDARONE; ION CHANNEL; PLACEBO; POTASSIUM; SODIUM;

BRADYCARDIA; CHAGAS DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DEFIBRILLATOR; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG CONTRAINDICATION; DRUG SAFETY; EDITORIAL; ELECTROLYTE DISTURBANCE; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPOKALEMIA; HYPOMAGNESEMIA; ISCHEMIC HEART DISEASE; KIDNEY DISEASE; MORTALITY; PRIORITY JOURNAL; SUDDEN DEATH; SURVIVAL; SYSTOLIC BLOOD PRESSURE; TORSADE DES POINTES; TREATMENT OUTCOME;

AMIODARONE; ANTI-ARRHYTHMIA AGENTS; CLINICAL TRIALS; HEART FAILURE, CONGESTIVE; HUMANS;

EID: 32844460455     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.332.7537.317     Document Type: Editorial

References (11)

1. Piepoli M, Villani GQ, Ponikowski P, Wright A, Flather MD, Coats AJ. Overview and meta-analysis of randomised trials of amiodarone in chronic heart failure. Int J Cardiol 1998;66:1-10.
2. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352:225-37.
3. Luu M, Stevenson WG, Stevenson LW, Baron K, Walden J. Diverse mechanisms of unexpected cardiac arrest in advanced heart failure. Circulation 1989;80:1675-80.
4. Connolly SJ. Evidence-based analysis of amiodarone efficacy and safety. Circulation 1999;100:2025-34.
5. Gupta S, Neyses L. Diuretic usage in heart failure: a continuing conundrum in 2005. Eur Heart J 2005;26:644-9.
6. Hauptman PJ, Kelly RA. Digitalis. Circulation 1999;99:1265-70.
7. The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 1997;336:525-33.
8. Khand AU, Rankin AC, Kaye GC, Cleland JG. Systematic review of the management of atrial fibrillation in patients with heart failure. Eur Heart J 2000;21:614-32.
9. Pauker SG, Estes NA, Salem DN. Preventing sudden cardiac death: can we afford the benefit? Ann Intern Med 2005;142:664-6.
10. Waldo AL, Camm AJ, deRuyter H, Friedman PL, MacNeil DJ, Pauls JF, et al. Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. Lancet 1996;348:7-12.
11. Sanofi-Synthelabo Italy. Discontinuation of one of the studies (ANDROMEDA) with dronedarone. 17 Jan 2003. www.sanofi-synthelabo. it/live/it/en/layout.jsp?cnt=F4BA0D93-F93C-408C-B594-0EF1A67DA 40F (accessed 29 Dec 2005).